Telos Rx PT-141 Review: Plans, Format, Pricing, and Open Questions

Telos Rx is unusually explicit that compounded medications are not FDA-approved. Its PT-141 product details and exact plan pricing are less visible publicly, so the value decision depends on what the intake and checkout reveal.

Research review by the EdClinic Editorial Team · our research standards · not a substitute for professional medical advice

The short verdict

Telos Rx may appeal to someone specifically seeking peptide-focused care and willing to use a compounded prescription after clinician review. The site’s repeated statement that compounded drugs are not FDA-approved is a meaningful transparency strength.

The weakness is product-level specificity. The public pages we could verify describe PT-141 and the overall care model but do not provide a simple, complete PT-141 price-and-quantity table comparable with BraveRX’s formula page.

Do not purchase based on the general “first month as low as $49” banner. A sexual-health protocol may have a different first-month charge, commitment discount, route, or refill total.

What Telos says about PT-141

Telos describes PT-141 as bremelanotide, a melanocortin agonist that works through a different pathway than vascular ED medications. Its editorial material correctly notes that compounded PT-141 is not FDA-approved. The women’s program page distinguishes branded Vyleesi from compounded PT-141 and describes as-needed subcutaneous dosing.

The men’s page includes PT-141 in the sexual-health offering and testimonials, but the public crawl did not provide a complete male product card with concentration, number of doses, or exact route. Those are not minor details. An injectable, nasal, or other compounded preparation cannot be compared by molecule name alone.

Ask the prescriber and pharmacy to identify the route and concentration in writing before payment.

Evidence for men

Bremelanotide has male ED research, including a randomized intranasal trial in sildenafil nonresponders that found better response and satisfaction measures than placebo. Earlier melanocortin studies also observed erections in small male samples.

Vyleesi’s approved indication does not include men, and its label says it is not for performance enhancement. A Telos prescription for a man is therefore outside the approved male indication and, when compounded, is also a non-FDA-approved finished product.

The best interpretation is not “unproven” or “proven miracle.” It is a plausible off-label option with limited male evidence, route-specific uncertainty, and a safety profile that warrants medical selection.

Pricing and commitment length

Telos’s homepage says the first month can be as low as $49 across its broader catalog. Affiliate information supplied to EdClinic listed PT-141 first-month pricing from roughly $40 to $249 depending on plan length. Because the public product-specific table was not visible in our review, we cannot confirm which amount buys which PT-141 quantity.

Longer commitments often reduce the monthly equivalent while increasing the total amount the customer authorizes. Record the first charge, later charge, number of shipments, dose count, supplies, clinician support, shipping, and cancellation rights.

A low first month can coexist with a high total commitment. Compare annualized cost and expected usage, especially for an as-needed product.

How the care model is presented

Telos says it is a technology and administrative-services platform and that medical services are provided by an independent U.S.-licensed telehealth group. It describes an online-first, asynchronous process, often without a required video appointment, with care-team messaging and shipping included in many programs.

The site also displays LegitScript certification and says medications are compounded in the United States. LegitScript certification evaluates aspects of healthcare merchant legitimacy; it does not turn a compounded drug into an approved product or validate a performance claim.

Confirm the medical group, dispensing pharmacy, state availability, response time for urgent medication questions, and whether laboratory testing is relevant to the sexual-health plan.

Safety questions that should be answered

For the approved Vyleesi injection, uncontrolled hypertension and known cardiovascular disease are contraindications. Blood pressure can rise transiently after dosing, and nausea is common. Hyperpigmentation is a recognized risk, especially with frequent dosing.

A compounded preparation may use a different concentration or route, so the pharmacy instructions control. It is still reasonable to ask how blood pressure is assessed, what nausea plan is safe, how often the product may be used, and what skin changes should trigger discontinuation.

The approved label also notes effects on gastric emptying and oral-drug absorption and warns against oral naltrexone products intended for alcohol or opioid dependence. A complete medication list matters.

Who it fits

Telos may fit a patient who understands the off-label context, wants peptide-focused telehealth, and values explicit compounding disclosures. It may be more attractive when standard PDE5 treatment was inadequate and a clinician has a reason to explore a central mechanism.

It is less appropriate for someone who wants an FDA-approved male indication, a conventional generic tablet, fully public per-dose pricing, or no plan commitment.

The decision should come after clarifying whether the complaint is desire, arousal, erection firmness, or a combination. PT-141 should not be used as a substitute for basic cardiovascular and medication evaluation.

Frequently asked questions

Is Telos Rx PT-141 FDA-approved for men?

No. The compounded product is not FDA-approved, and the approved bremelanotide label does not include men.

What route does Telos use?

The public pages reviewed did not provide enough consistent product-level detail to state the route for every male plan. Confirm whether the prescription is injectable, nasal, or another form.

How much does it cost?

Telos advertises some first-month programs from $49, while program materials supplied to EdClinic indicated a wider PT-141 range by commitment length. Confirm quantity and renewal price in checkout.

Does Telos require a video visit?

The platform describes an asynchronous online-first model, but state law and clinician judgment can affect the encounter required.

Build a verification record before the first dose

Save the product page, checkout summary, prescription instructions, pharmacy label, and cancellation terms as a single record. Telehealth pages change quickly, and a later support conversation is easier when the exact formula, strength, count, charge, and renewal date are documented. A screenshot is especially useful when a provider uses several landing pages with different starting prices.

At the clinical level, write down every prescription, over-the-counter medication, supplement, nitrate or “poppers” exposure, cardiovascular diagnosis, blood-pressure issue, and prior ED treatment. Include what happened with earlier medication: dose, timing, food, alcohol, stimulation, benefit, and side effects. That history is more useful than saying a product “did not work.”

After treatment begins, record benefit and adverse effects without repeatedly testing a severe reaction. Contact the prescriber when the formula is ineffective, produces persistent symptoms, or creates uncertainty about another medication. Use emergency care for chest pain, fainting, sudden vision or hearing change, or an erection lasting more than four hours.